Lallemand Health Solutions’ Rosell Institute for Microbiome and Probiotics has published findings of a women’s and infant health study supporting its latest probiotic formulation, Prenatis. The formula contains two proprietary strains — Lactobacillus rhamnosus Rosell-11 and Bifidobacterium bifidum HA-132. It is shown to support maternal health during pregnancy and help develop a healthy infant microbiome through breastfeeding. Prenatis can be combined with other probiotic strains and enriched with essential nutrients such as vitamin B9 (folic acid). It is available in a variety of convenient formats for expectant mothers, including sachets, sticks, orodispersible powders, and capsules in blisters or bottles.
